ROTHBLATT MARTINE A sold UTHR
March 16, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 160 shares of United Therapeutics Corporation at $537.37 per share, a transaction worth $86.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
160
Price
$537.37
Total value
$86.0K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 16, 2026
Filing dateMarch 17, 2026
Shares owned after40,513
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.